Recommendations on the Clinical Trial Programme for Diabetes Medicines
Diabetes is a serious public health problem and one of the major chronic noncommunicable diseases. A lengthy stepwise treatment, and the need for an individualised approach to antidiabetic therapy, pose serious challenges for medicine developers. For all new hypoglycaemic medicines, there has been a...
Main Authors: | I. A. Proskurina, E. A. Petraneva, D. V. Goryachev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
NEICON ISP LLC
2021-07-01
|
Series: | Ведомости Научного центра экспертизы средств медицинского применения |
Subjects: | |
Online Access: | https://www.vedomostincesmp.ru/jour/article/view/340 |
Similar Items
-
Current Approaches to Planning and Conducting Clinical Trials of Medicinal Products for the Treatment of Crohn's Disease
by: А. N. Bogdanov, et al.
Published: (2020-06-01) -
Planning of clinical trial programmes for medicines for the treatment of obesity
by: I. A. Proskurina, et al.
Published: (2023-12-01) -
Estimands: a new way of interpreting the results of clinical essays
by: Javier MartÃn-Vallejo, et al.
Published: (2023-01-01) -
Planning a Clinical Development Programme for Medicines for Bronchial Asthma
by: E. S. Petrova, et al.
Published: (2021-03-01) -
Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions
by: Brennan C. Kahan, et al.
Published: (2020-09-01)